Diabetes 53:S104-S112, 2004
© 2004 by the American Diabetes Association, Inc.
Section III: The Beta-Cell ATP-Sensitive K+ Channels |
Toward Linking Structure With Function in ATP-Sensitive K+ Channels
Joseph Bryan1,
Wanda H. Vila-Carriles2,
Guiling Zhao1,
Audrey P. Babenko1, and
Lydia Aguilar-Bryan1,3
1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas
2 Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas
3 Department of Medicine, Baylor College of Medicine, Houston, Texas
Advances in understanding the overall structural features of inward rectifiers and ATP-binding cassette (ABC) transporters are providing novel insight into the architecture of ATP-sensitive K+ channels (KATP channels) (KIR6.0/SUR)4. The structure of the KIR pore has been modeled on bacterial K+ channels, while the lipid-A exporter, MsbA, provides a template for the MDR-like core of sulfonylurea receptor (SUR)-1. TMD0, an NH2-terminal bundle of five -helices found in SURs, binds to and activates KIR6.0. The adjacent cytoplasmic L0 linker serves a dual function, acting as a tether to link the MDR-like core to the KIR6.2/TMD0 complex and exerting bidirectional control over channel gating via interactions with the NH2-terminus of the KIR. Homology modeling of the SUR1 core offers the possibility of defining the glibenclamide/sulfonylurea binding pocket. Consistent with 30-year-old studies on the pharmacology of hypoglycemic agents, the pocket is bipartite. Elements of the COOH-terminal half of the core recognize a hydrophobic group in glibenclamide, adjacent to the sulfonylurea moiety, to provide selectivity for SUR1, while the benzamido group appears to be in proximity to L0 and the KIR NH2-terminus.
Address correspondence and reprint requests to Joseph Bryan, PhD, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030. E-mail: jbryan{at}bcm.tmc.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Proks, K. Shimomura, T. J. Craig, C. A.J. Girard, and F. M. Ashcroft
Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome
Hum. Mol. Genet.,
August 15, 2007;
16(16):
2011 - 2019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hosy, R. Derand, J. Revilloud, and M. Vivaudou
Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123
J. Physiol.,
July 1, 2007;
582(1):
27 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hambrock, C. B. de Oliveira Franz, S. Hiller, A. Grenz, S. Ackermann, D. U. Schulze, G. Drews, and H. Osswald
Resveratrol Binds to the Sulfonylurea Receptor (SUR) and Induces Apoptosis in a SUR Subtype-specific Manner
J. Biol. Chem.,
February 2, 2007;
282(5):
3347 - 3356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Vila-Carriles, G. Zhao, and J. Bryan
Defining a binding pocket for sulfonylureas in ATP-sensitive potassium channels
FASEB J,
January 1, 2007;
21(1):
18 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-F. Yan, J. Casey, and S.-L. Shyng
Sulfonylureas Correct Trafficking Defects of Disease-causing ATP-sensitive Potassium Channels by Binding to the Channel Complex
J. Biol. Chem.,
November 3, 2006;
281(44):
33403 - 33413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System.
Physiol Rev,
October 1, 2006;
86(4):
1179 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Babenko, M. Polak, H. Cave, K. Busiah, P. Czernichow, R. Scharfmann, J. Bryan, L. Aguilar-Bryan, M. Vaxillaire, and P. Froguel
Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
N. Engl. J. Med.,
August 3, 2006;
355(5):
456 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Proks, A. L. Arnold, J. Bruining, C. Girard, S. E. Flanagan, B. Larkin, K. Colclough, A. T. Hattersley, F. M. Ashcroft, and S. Ellard
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes
Hum. Mol. Genet.,
June 1, 2006;
15(11):
1793 - 1800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hambrock, C. B. de Oliveira Franz, S. Hiller, and H. Osswald
Glibenclamide-Induced Apoptosis Is Specifically Enhanced by Expression of the Sulfonylurea Receptor Isoform SUR1 but Not by Expression of SUR2B or the Mutant SUR1(M1289T)
J. Pharmacol. Exp. Ther.,
March 1, 2006;
316(3):
1031 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|